Sunshine Biopharma (SBFM) Q2 2026 Earnings

13MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.5
-1.7
-0.91
-0.11

Details

Expected EPS
-2.5
Actual EPS
-2.5
Surprise EPS
0
Surprise Percent
+0%

Description

Sunshine Biopharma (SBFM) has reported earnings of -2.5 per share for Q2 2026.

0 Comments

Share your thoughts